GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (STU:76D) » Definitions » Net Issuance of Preferred Stock

Medesis Pharma (STU:76D) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Medesis Pharma Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Medesis Pharma's net issuance of preferred for the six months ended in Jun. 2024 was €0.00 Mil. The number is 0, which means that Medesis Pharma has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Medesis Pharma's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Medesis Pharma Net Issuance of Preferred Stock Historical Data

The historical data trend for Medesis Pharma's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma Net Issuance of Preferred Stock Chart

Medesis Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Preferred Stock
Get a 7-Day Free Trial - - - - -

Medesis Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Medesis Pharma Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medesis Pharma Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Medesis Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (STU:76D) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
XPAR:ALTHX XPAR:ALBPS XPAR:ALNEV XPAR:ALINT XPAR:ALTME XPAR:ALOPM XPAR:ALTAO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170
Traded in Other Exchanges
ALMDP:France 76D:Germany
Address
Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670
Website
https://www.medesispharma.com
Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines